Form 4 for PALI PALISADE BIO, INC.
Accepted 2024-05-28 00:00:00 ET · period of report 2024-05-24 · accession 0001493152-24-021431 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-05-28 | 2024-05-24 | PALI | Finley John David | CEO, CFO, Dir | P - Purchase | $4.81 | +1,000 | 8,437 | +13% | +$4,810 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.01 | 2024-05-24 | P | A | 1,000 | $4.81 | 8,437 | D | — | — | (F1) Reporting Person purchased 1,000 shares of Common Stock of Issuer at a price per share of $4.81 on May 24, 2024. |